HF
HKPD

HRT Financial’s Cellyan Biotechnology HKPD Stock Holding History

HRT Financial’s Portfolio HKPD Stock Details HKPD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
+41,824
New +$22.9K ﹤0.01% 3954

Other funds holding HKPD

SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's HKPD Position: Q2 2026 in Review

HRT Financial opened a new position in Cellyan Biotechnology (HKPD) in Q2 2026: 41,824 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #3954 among its holdings.

6 funds tracked by Wall St. Rank hold HKPD as of Q2 2026.

  • HRT Financial held 41,824 shares of Cellyan Biotechnology worth $15K as of Q2 2026.
  • Cellyan Biotechnology was a new HRT Financial position in Q2 2026.
  • Cellyan Biotechnology made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3954 holding.
  • 6 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.